SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 398 filers reported holding SEATTLE GENETICS INC in Q4 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,993,000 | -18.8% | 23,500 | -44.8% | 0.06% | -30.6% |
| Q1 2020 | $4,915,000 | +42.9% | 42,600 | +41.5% | 0.08% | +77.1% |
| Q4 2019 | $3,439,000 | +316.8% | 30,100 | +98.4% | 0.05% | +700.0% |
| Q4 2017 | $825,000 | 0.0% | 15,171 | 0.0% | 0.01% | -53.8% |
| Q3 2017 | $825,000 | -13.3% | 15,171 | -17.5% | 0.01% | -18.8% |
| Q2 2017 | $952,000 | -16.8% | 18,400 | +1.1% | 0.02% | -27.3% |
| Q1 2017 | $1,144,000 | +19.2% | 18,200 | 0.0% | 0.02% | +10.0% |
| Q4 2016 | $960,000 | – | 18,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,046,060 | $2,892,270,000 | 23.68% |
| Lagoda Investment Management, L.P. | 88,615 | $5,021,000 | 8.38% |
| Matrix Capital Management Company, LP | 3,141,852 | $178,017,000 | 5.90% |
| Opus Point Partners Management, LLC | 19,127 | $1,084,000 | 2.39% |
| EMORY UNIVERSITY | 41,539 | $2,354,000 | 1.86% |
| Capital International Sarl | 238,100 | $13,491,000 | 1.62% |
| Rhenman & Partners Asset Management AB | 242,198 | $13,723,000 | 1.57% |
| CAPITAL GUARDIAN TRUST CO | 1,341,050 | $75,984,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 42,500 | $1,890,000 | 1.17% |
| JGP Global Gestao de Recursos Ltda. | 16,524 | $936,000 | 1.14% |